Trimazosin hydrochloride anhydrous
- Level
- Commodity
- Parent
- 51263000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51263015This classification denotes an alpha-adrenergic blocking agent with the molecular formula C20H29N5O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OT29P74170, chemically known as 1-piperazinecarboxylic acid, 4-(4-amino-6,7,8-trimethoxy-2-quinazolinyl)-, 2-hydroxy-2-methylpropyl ester, hydrochloride (1:1), but more generally known as trimazosin hydrochloride anhydrous, which bears US NIH Compound Identifier 64748. European Medicines Agency schedules trimazosin hydrochloride anhydrous or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11298MIG. Most nations, for tariff purposes, schedule trimazosin hydrochloride anhydrous under HS 29335995. SMILES: CC(C)(COC(=O)N1CCN(CC1)C2NC3C(CC(C(C3OC)OC)OC)C(N2)N)O.CL.
Same parent
Under 51263000 · 17Activities that produce or sell this
KBLI · 8Inherited from family 51260000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.